$17.70
+
$1.10 (6.63%)
End-of-day quote: 05/22/2024
NasdaqCM:TGTX
TG Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | SWX | Hold | CHF93.16 | CHF105.00 | 0.00% | 9 | CHF190.08B |
| SAN | Sanofi | ENXTPA | Outperform | 90.80€ | 102.80€ | 0.00% | 9 | 113.51€B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $42.34 | $58.15 | 0.00% | 10 | $85.83B |
| MRK | Merck KGaA | XTRA | Outperform | 168.50€ | 190.06€ | 0.00% | 4 | 73.26€B |
| BIIB | Biogen | NasdaqGS | Outperform | $225.21 | $299.62 | 0.00% | 13 | $32.79B |
| BAYN | Bayer | XTRA | Hold | 28.40€ | 45.15€ | 0.00% | 4 | 27.90€B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.88 | $11.59 | 0.00% | 9 | $19.12B |
| GMAB | Genmab A/S | CPSE | Outperform | kr2.06k | kr2.71k | 0.00% | 14 | kr132.66B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.21 | $33.27 | 0.00% | 3 | $4.11B |
